Drug Database
Back to search

Poland· PL-100482561

Arexvy

A respiratorisches-synzytial-virus impfstoffe product containing szczepionka przeciw syncytialnemu wirusowi dróg oddechowych (rsv) (rekombinowana, z adiuwantem), registered in Poland by GlaxoSmithKline Biologicals S.A.. The same ATC class is registered in 11 of our 19 countries.

ATC J07BX05

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedArexvyATCJ07BX05REGISTER NO.PL-100482561PACKS LISTED4CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about szczepionka przeciw syncytialnemu wirusowi dróg oddechowych (rsv) (rekombinowana, z adiuwantem)Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Respiratorisches-synzytial-virus impfstoffe is registered in 11 of 19 countries.

Countries holding a registration under ATC J07BX05 (respiratorisches-synzytial-virus impfstoffe), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose
Search respiratorisches-synzytial-virus impfstoffe products by name

Respiratorisches-synzytial-virus impfstoffe · ATC J07BX05

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Szczepionka przeciw syncytialnemu wirusowi dróg oddechowych (RSV) (rekombinowana, z adiuwantem)
Manufacturer
GlaxoSmithKline Biologicals S.A.
Country
Poland (PL)
ATC code
J07BX05
ATC class
Respiratorisches-Synzytial-Virus Impfstoffe
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 4

1 priced
  • gtin
    05909991513610
    1 fiol. proszku + 1 fiol. zawiesiny
    PLN 817.72
  • gtin
    05909991513627
  • gtin
    05901549673074
  • gtin
    05901549673081

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Respiratorisches-synzytial-virus impfstoffe in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All respiratorisches-synzytial-virus impfstoffe products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9e662995-1823-4975-bfaf-6cea4b7597c4
GET /v1/drugs/9e662995-1823-4975-bfaf-6cea4b7597c4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Proszek i zawiesina do sporządzania zawiesiny do wstrzykiwań",
  "source": "urpl",
  "strength": "-",
  "packaging": "05909991513610 ¦ Rp ¦ EU/1/23/1740/001 ¦ 149969\n1 fiol. 0,5 ml zawiesiny ¦ 1 fiol. 120 mcg proszku\n05909991513627 ¦ Rp ¦ EU/1/23/1740/002 ¦ 149970\n10 fiol. 0,5 ml zawiesiny ¦ 10 fiol. 120 mcg proszku\n05901549673074 ¦ Rp ¦ EU/1/23/1740/003 ¦ 167847\n1 fiol.  ¦ 1 amp.-strzyk.  bez igły\n05901549673081 ¦ Rp ¦ EU/1/23/1740/004 ¦ 167848\n10 fiol.  ¦ 10 amp.-strzyk.  bez igieł",
  "substance": "Antygen RSVPreF3 120 mcg/0.5 ml + Quillaja saponaria 25 mcg/0.5 ml",
  "common_name": "Szczepionka przeciw syncytialnemu wirusowi dróg oddechowych (RSV) (rekombinowana, z adiuwantem)",
  "pl_product_id": "100482561",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}
API referenceMCP serverPlans

See everything about respiratorisches-synzytial-virus impfstoffe.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console